CEO, Lengo Therapeutics
Tuck put me on a path that was different than I initially planned, but actually worked out better than I ever could have dreamed.
Enoch Kariuki T’11’s success is rooted in the resourcefulness of his mother, who had been forced to leave school after the first grade. What she lacked in formal education, she made up for with determination and an innate talent for business. She built a wholesaling company and then a beer distributorship, and funneled every shilling into her children’s education.
Kariuki gained admission to one of the premier high schools in Kenya and was later accepted to a number of prestigious American universities that he couldn’t afford to attend, even with generous financial aid. Texas Southern, a historically black university with a well-regarded pharmacy program, offered a full scholarship. “That’s how I ended up in Texas,” Kariuki says. “I had no idea where in the world Texas was.”
A mentor pulled strings to extend his aid, and Kariuki earned his doctorate in pharmacology. He enjoyed the science but also was drawn to the business of pharmaceuticals, and a professor suggested he do a postdoctoral fellowship with one of the major drug companies. He had his choice of programs and chose a Bristol Myers Squibb fellowship for its unique focus on R&D strategy and analytics.
At Bristol, Kariuki found his calling at the confluence of science and commerce, and also recognized the need to improve his business foundation. “I wanted a top-ranked MBA program with a strong health initiative and a lot of international students,” Kariuki says. Tuck provided all of the above plus a scholarship, but the school’s most lasting impact stems from the nurturing environment he found there, from the mentorship of senior faculty like Michael Zubkoff, to classmates in his study groups and alumni he’d never even met.
“I came to Tuck with a very clear plan,” Kariuki says. “I was going to get my MBA and go back to industry. Then I got to Tuck and there was a whole new world of private equity and venture capital and investment banking.” Seeking guidance, he went to the career office, where a counselor handed him a list of five prominent alumni, each of whom spent an hour with him. Their advice? Spread your wings.
“Paul Clark, in particular, said, ‘Try something different. This is your chance to explore,’” Kariuki recalls. “Tuck put me on a different path that was different than I initially planned, but actually worked out better than I ever could have dreamed.”
Kariuki’s specific blend of scientific knowledge and business training is suited to the current moment in biotech, where breakthroughs in the understanding of the human genome and technologies such as CRISPR have opened a world of new opportunities. Within this space, Kariuki says, “I've chosen to spend my time working and investing in companies that are truly making an impact on patient lives.”
When Kariuki joined Synthorx, which is pioneering the use of synthetic DNA to target cancer and autoimmune therapies, the company was valued at $75 million. Two years later, it sold for $2.5 billion. His new company VelosBio, which was recently acquired by Merck for $2.75 billion, is developing a novel targeting technology for Interleukin-2, an effective but highly toxic chemotherapy drug.
“We used to take the shotgun approach,” he explains. “If you had cancer we’d give it chemo and it kills cancer cells, but it also kills healthy cells. Now we can have the proven lifesaving effect of this drug, without the toxicity.”
As VP of interventional pain at Medtronic, mission-driven leader Anu Codaty T’04 is helping to alleviate patients’ pain, restore health, and extend human life.Read More
Julie Skaff’s health care career has provided her the opportunity to make meaningful change, and fostered a deep appreciation for the type of wise leadership the industry needs.Read More
Phong Nguyen made the leap to health care with Accolade, a provider of personalized health and benefits solutions to employees and their familiesRead More
After Tuck, Daych worked as “a generalist in the buyout world,” before making the conscious decision to focus on health care during a time when the industry was becoming dramatically more complex.Read More
E. Selemon Asfaw
E. Selemon Asfaw’s interest in health care came later, awakened during a summer internship at Goldman Sachs and sharpened the next year in a Tuck elective.Read More
France began his career at McKinsey as a health care consultant, where his exposure to urgent care centers in Portland, Oregon called to mind a Tuck lecture entitled “Is Your Industry Ready for a Rollup?”Read More
Simplifying the Search for Therapy: Meet Jonathan TranPham T’10
Jonathan TranPham T’10, founder & CEO of reflect, wants to improve lives by making it easier to access quality mental health resources.Read More
Laura Ward T’89 Is Tackling the Mental Health Stigma
Armed with an MBA and an MPH, Laura Ward T’89 is building a more informed health care model for individuals with histories of trauma and abuse.Read More
The Humble Leader
In 2015, Tuck alumna Aisha Barry decided to change the course of her career to help other people who felt immobilized by the health care system and a disease diagnosis.Read More
Before you know what she is, you first need to know what Betsabeh Hermann T’13 is not: She is not an astronaut. Or at least, not yet anyway.Read More
In pioneering new health-care models emphasizing preventive care, John Sory T’93 overcame skepticism in the most direct way possible: He guaranteed better results.Read More
At Boston-based nonprofit Health Leads, Lea Tompsett T’06 is working with health care providers and social service agencies to ensure patients have access to basic necessities: food, transportation, housing.Read More
Duncan Reece T’08 was seven years into a career in finance when he realized he wanted to have a greater impact on the world around him. He found that connection in the health-care industry.Read More
James “Jim” Lindstrom
Jim Lindstrom T’01 has a career of both investment and senior operational roles—a unique perspective to lead a multinational corporation in today’s dynamic environment.Read More
Amrit Ray T’02 is working to improve compassionate access to investigational medicines and medicines for children—callings that combine his professional strengths with his personal convictions.Read More
Not many people in ball bearing sales finish their careers in venture capital. For Mike Carusi T’93, now one of the most successful health care investors in Silicon Valley, that unlikely journey started with two eye-opening years at Tuck.Read More